SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-14-000771
Filing Date
2014-03-31
Accepted
2014-03-31 16:31:53
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K biostar10k123113.htm 10-K 1846431
2 EX-23.1 ex23-1.htm EX-23.1 4107
3 EX-31.1 ex31-1.htm EX-31.1 17076
4 EX-31.2 ex31-2.htm EX-31.2 16933
5 EX-32.1 ex32-1.htm EX-32.1 8003
6 EX-32.2 ex32-2.htm EX-32.2 7439
13 GRAPHIC chart.jpg GRAPHIC 41061
  Complete submission text file 0001185185-14-000771.txt   9097580

Data Files

Seq Description Document Type Size
7 EX-101.INS bspm-20131231.xml EX-101.INS 1421994
8 EX-101.SCH bspm-20131231.xsd EX-101.SCH 65934
9 EX-101.CAL bspm-20131231_cal.xml EX-101.CAL 56972
10 EX-101.DEF bspm-20131231_def.xml EX-101.DEF 310158
11 EX-101.LAB bspm-20131231_lab.xml EX-101.LAB 469294
12 EX-101.PRE bspm-20131231_pre.xml EX-101.PRE 321069
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34708 | Film No.: 14730486
SIC: 2834 Pharmaceutical Preparations